Trade

with

Medgenics Inc
(Amex: MDGN)
AdChoices
5.09
+0.13
+2.62%
After Hours :
5.08
-0.01
-0.20%

Open

5.01

Previous Close

4.96

Volume (Avg)

19.13k (46.62k)

Day's Range

4.89-5.10

52Wk Range

4.71-9.00

Market Cap.

93.80M

Dividend Rate ( Yield )

-

Beta

1.95

Shares Outstanding

18.91M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 0

    • Net Income

    • -17.13M

    • Market Cap.

    • 93.80M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.95

    • Forward P/E

    • -

    • Price/Sales

    • -

    • Price/Book Value

    • 7.62

    • Price/Cash flow

    • -7.35

      • EBITDA

      • -16.92M

      • Return on Capital %

      • -78.95

      • Return on Equity %

      • -101.84

      • Return on Assets %

      • -78.95

      • Book Value/Share

      • 0.65

      • Shares Outstanding

      • 18.91M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 14.00

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -0.94

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 0.00

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 82.75

            • Pre-Tax Margin

            • -

            • 39.38

            • Net Profit Margin

            • -

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 6.03

              • 2.92

              • Quick Ratio

              • 6.03

              • 2.35

              • Interest Coverage

              • -190.48

              • 38.02

              • Leverage Ratio

              • 1.29

              • 2.21

              • Book Value/Share

              • 0.65

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -5.42

                • 196.08

                • P/E Ratio 5-Year High

                • -17.51

                • 634.30

                • P/E Ratio 5-Year Low

                • -2.22

                • 124.82

                • Price/Sales Ratio

                • -

                • 9.12

                • Price/Book Value

                • 7.82

                • 8.26

                • Price/Cash Flow Ratio

                • -7.35

                • 47.39

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -101.84

                        (-)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -78.95

                        (-179.00)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -101.31

                        (-)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • -

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -17.82M
                      Operating Margin
                      -
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -7.35
                      Ownership

                      Institutional Ownership

                      16.79%

                      Top 10 Institutions

                      15.67%

                      Mutual Fund Ownership

                      9.54%

                      Float

                      87.49%

                      5% / Insider Ownership

                      4.43%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Undrly L&G Pen Managed

                      •  

                        577,690

                      • -14.88

                      • 3.12

                      • Vanguard Total Stock Mkt Idx

                      •  

                        246,622

                      • 0.00

                      • 1.30

                      • Edinburgh Worldwide

                      •  

                        224,650

                      • 0.00

                      • 1.20

                      • Baillie Gifford Global Discovery

                      •  

                        136,000

                      • 0.00

                      • 0.72

                      • L & G Eq In Fd

                      •  

                        126,058

                      • -31.16

                      • 0.67

                      • Vanguard Extended Market Index Fund

                      •  

                        110,428

                      • 1.44

                      • 0.58

                      • Undrly L&G Pen Distribution

                      •  

                        93,439

                      • -57.83

                      • 0.50

                      • Marlborough Special Situations Fd

                      •  

                        87,662

                      • 0.00

                      • 0.42

                      • Bridgeway Ultra Small Company Market

                      •  

                        61,000

                      • 0.00

                      • 0.32

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        53,680

                      • 16.39

                      • 0.28

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • ACNYC LLC

                      •  

                        902,782

                      • -11.87%

                      • 4.88

                      • Legal & General Group PLC

                      •  

                        450,000

                      • 0.00%

                      • 2.44

                      • Baillie Gifford & Co Limited.

                      •  

                        360,650

                      • 0.00%

                      • 1.92

                      • Vanguard Group, Inc.

                      •  

                        356,135

                      • +5.23%

                      • 1.89

                      • Belmont Global Advisors, Inc.

                      •  

                        340,000

                      • 0.00%

                      • 1.81

                      • BlackRock Fund Advisors

                      •  

                        246,447

                      • +8.38%

                      • 1.31

                      • Marlborough International Management Limited

                      •  

                        87,662

                      • 0.00%

                      • 0.42

                      • Bridgeway Capital Management, Inc

                      •  

                        80,000

                      • 0.00%

                      • 0.43

                      • Perceptive Advisors LLC

                      •  

                        55,073

                      • -10.10%

                      • 0.29

                      • LPL Financial Corp

                      •  

                        52,359

                      • +1.63%

                      • 0.28

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Distressed

                      Style

                      Small Growth

                      Medgenics Inc was incorporated on 27th January 2000 in Delaware. It is a medical technology and therapeutics company. The Company and its subsidiary are engaged in the research and development of products in the field of biotechnolog...morey and associated medical equipment. The Company has developed a novel technology for the manufacture and delivery of therapeutic proteins continuously in patients using their own tissue. The company has also developed an Interferon Alpha secreting Biopump for the treatment of viral Hepatitis. The Company's Biopump Platform Technology converts a small piece of the patient’s own dermal skin tissue into a protein. Its proprietary device, the DermaVac, is used to extract a small piece of tissue via a form of needle biopsy from the skin’s lower level – the dermis – of patien...moret under local anesthesia. Its EPODURE Biopump is designed to provide a safer, more reliable, and more cost-effective anemia therapy. The Company face competition within protein/peptide therapeutics, directly from established competitors using alternative protein manufacturing and delivery methods for EPO and in many orphan and rare disease areas respectively. The Company's production, distribution, and marketing of products employing its technology, and its development activities, are subject to extensive governmental regulation in the United States and in other countries. In the United States, its products are regulated as biologics and medical devices and are subject to the Federal Food, Drug, and Cosmetic Act, as amended, and the regulations of the FDA, as well as to other federal, state, and local statutes and regulations.lessless

                      Key People

                      Michael F. Cola

                      CEO/Director/President

                      Dr. Sol J. Barer,PhD

                      Director/Chairman of the Board

                      Mr. John H. Leaman

                      CFO

                      Phyllis K. Bellin

                      Chief Accounting Officer/Secretary/Treasurer/Vice President, Divisional/Vice President, Subsidiary

                      Dr. Alastair Clemow,PhD

                      Director

                      • Medgenics Inc

                      • 435 Devon Park Drive

                      • Wayne, PA 19087

                      • USA.Map

                      • Phone: +1 610 254-4201

                      • Fax: -

                      • medgenics.com

                      Incorporated

                      2000

                      Employees

                      38

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: